Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
149.06
+4.49 (3.11%)
At close: Oct 31, 2025, 4:00 PM EDT
152.04
+2.98 (2.00%)
After-hours: Oct 31, 2025, 6:20 PM EDT
Repligen Stock Forecast
Stock Price Forecast
The 10 analysts that cover Repligen stock have a consensus rating of "Buy" and an average price target of $170.9, which forecasts a 14.65% increase in the stock price over the next year. The lowest target is $135 and the highest is $204.
Price Target: $170.9 (+14.65%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Repligen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 1 | 2 |
| Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Hold | 5 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $150 → $165 | Hold | Maintains | $150 → $165 | +10.69% | Oct 29, 2025 |
| Barclays | Barclays | Buy Maintains $160 → $175 | Buy | Maintains | $160 → $175 | +17.40% | Oct 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $155 → $175 | Buy | Maintains | $155 → $175 | +17.40% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $150 → $160 | Buy | Maintains | $150 → $160 | +7.34% | Oct 2, 2025 |
| HSBC | HSBC | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | +0.63% | Oct 1, 2025 |
Financial Forecast
Revenue This Year
740.99M
from 634.44M
Increased by 16.79%
Revenue Next Year
841.62M
from 740.99M
Increased by 13.58%
EPS This Year
1.72
from -0.46
EPS Next Year
2.23
from 1.72
Increased by 29.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 771.5M | 892.5M | |||
| Avg | 741.0M | 841.6M | |||
| Low | 702.1M | 778.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.6% | 20.4% | |||
| Avg | 16.8% | 13.6% | |||
| Low | 10.7% | 5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.82 | 2.59 | |||
| Avg | 1.72 | 2.23 | |||
| Low | 1.62 | 1.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 50.9% | |||
| Avg | - | 30.0% | |||
| Low | - | 6.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.